Bio-Techne TECH Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $209.82M+21.4% | $172.88M+19.3% | $144.96M-10.6% | $162.19M+15.3% | $140.67M-20.8% | ||
| $214.56M+16.2% | $184.61M+0.4% | $183.9M-11.1% | $206.88M-12.8% | $237.14M+8.8% | ||
| $201.18M-2.1% | $205.45M+1.1% | $203.19M+7.3% | $189.45M-0.9% | $191.08M+1.4% | ||
| $62.49M-16.1% | $74.49M-3.8% | $77.46M+107% | $37.46M-30.2% | $53.65M+7.9% | ||
| —— | —— | —— | $12.33M+162% | $4.7M+349% | ||
| $688.05M+7.9% | $637.43M+4.6% | $609.51M+0.2% | $608.3M-3.0% | $627.24M-1.2% | ||
| $232.99M-0.6% | $234.38M-2.5% | $240.33M-2.2% | $245.72M-2.5% | $251.98M+0.9% | ||
| $68.32M+0.1% | $68.25M-3.5% | $70.73M-3.6% | $73.4M-12.4% | $83.74M-1.9% | ||
| $977.8M-0.3% | $980.56M+0.2% | $978.91M-0.2% | $980.94M+1.3% | $968.61M+0.4% | ||
| $319.07M-4.8% | $334.99M-4.3% | $350.11M-4.2% | $365.6M-17.6% | $443.7M-3.8% | ||
| $264.37M-1.0% | $267.08M-3.4% | $276.56M-2.6% | $283.92M+5.6% | $268.99M-2.2% | ||
| $2.55B+1.1% | $2.52B-0.1% | $2.53B-1.2% | $2.56B-3.3% | $2.64B-1.0% | ||
| $23.49M-10.6% | $26.27M-12.9% | $30.16M+19.1% | $25.31M-20.0% | $31.64M-4.5% | ||
| $54.43M+20.9% | $45.03M+3.3% | $43.6M-33.7% | $65.79M+6.3% | $61.9M+15.5% | ||
| $38.43M+23.9% | $31.03M+1.9% | $30.45M-6.5% | $32.57M+0.9% | $32.27M+16.4% | ||
| $14.18M+3.4% | $13.71M-0.4% | $13.77M-2.3% | $14.1M+0.3% | $14.05M+4.0% | ||
| $2.97M+20.0% | $2.48M-13.1% | $2.85M-73.6% | $10.77M+197% | $3.63M+15.5% | ||
| $153.28M+9.2% | $140.43M-2.8% | $144.55M-17.8% | $175.85M+3.9% | $169.2M+4.9% | ||
| $200M-23.1% | $260M-13.3% | $300M-13.3% | $346M+4.8% | $330M+10.0% | ||
| $76.14M-1.4% | $77.19M-4.4% | $80.7M-3.9% | $83.96M+5.7% | $79.45M-2.7% | ||
| $90.32M-0.6% | $90.9M-3.8% | $94.47M-3.7% | $98.06M+4.9% | $93.5M-1.7% | ||
| $21.67M-6.1% | $23.08M-3.1% | $23.81M-12.1% | $27.08M+73.0% | $15.66M+38.1% | ||
| $1.57M+0.4% | $1.56M+0.1% | $1.56M+0.5% | $1.55M-1.1% | $1.57M-0.7% | ||
| $1.01B+4.2% | $964.96M+2.0% | $946.12M+3.8% | $911.09M+1.0% | $902.12M+3.0% | ||
| $1.15B+3.5% | $1.11B+2.2% | $1.08B+1.5% | $1.07B-10.9% | $1.2B-7.0% | ||
| -$66.86M-7.2% | -$62.34M+3.2% | -$64.4M-7.5% | -$59.88M+27.0% | -$82.05M+4.2% | ||
| $2.09B+3.7% | $2.01B— | —— | $1.92B-4.9% | $2.02B-2.9% | ||
| $2.55B+1.1% | $2.52B-0.1% | $2.53B-1.2% | $2.56B-3.3% | $2.64B-1.0% | ||
| $62.49M-16.1% | $74.49M-3.8% | $77.46M+107% | $37.46M-30.2% | $53.65M+7.9% | ||
| $264.37M-1.0% | $267.08M-3.4% | $276.56M-2.6% | $283.92M+5.6% | $268.99M-2.2% | ||
| $68.32M+0.1% | $68.25M-3.5% | $70.73M-3.6% | $73.4M-12.4% | $83.74M-1.9% | ||
| —— | —— | —— | $10.31M— | —— | ||
| $319.07M-4.8% | $334.99M-4.3% | $350.11M-4.2% | $365.6M-17.6% | $443.7M-3.8% | ||
| $68.32M+0.1% | $68.25M-3.5% | $70.73M-3.6% | $73.4M-12.4% | $83.74M-1.9% | ||
| $264.37M-1.0% | $267.08M-3.4% | $276.56M-2.6% | $283.92M+5.6% | $268.99M-2.2% | ||
| $68.32M+0.1% | $68.25M-3.5% | $70.73M-3.6% | $73.4M-12.4% | $83.74M-1.9% | ||
| $264.37M-1.0% | $267.08M-3.4% | $276.56M-2.6% | $283.92M+5.6% | $268.99M-2.2% | ||
| $54.43M+20.9% | $45.03M+3.3% | $43.6M-33.7% | $65.79M+6.3% | $61.9M+15.5% | ||
| $17.68M-13.1% | $20.34M+6.0% | $19.18M-25.3% | $25.66M+7.4% | $23.91M-13.2% | ||
| $2.97M+20.0% | $2.48M-13.1% | $2.85M-73.6% | $10.77M+197% | $3.63M+15.5% | ||
| $17.68M-13.1% | $20.34M+6.0% | $19.18M-25.3% | $25.66M+7.4% | $23.91M-13.2% | ||
| $54.43M+20.9% | $45.03M+3.3% | $43.6M-33.7% | $65.79M+6.3% | $61.9M+15.5% | ||
| $2.09M+32.6% | $1.58M-65.3% | $4.55M+176% | $1.65M-9.3% | $1.81M-31.1% | ||
| $200M-23.1% | $260M-13.3% | $300M-13.3% | $346M+4.8% | $330M+10.0% | ||
| $290.32M-17.3% | $350.9M-11.0% | $394.47M-11.2% | $444.06M+4.9% | $423.5M+7.2% | ||
| $1.01B+4.2% | $964.96M+2.0% | $946.12M+3.8% | $911.09M+1.0% | $902.12M+3.0% | ||
| $1.57M+0.4% | $1.56M+0.1% | $1.56M+0.5% | $1.55M-1.1% | $1.57M-0.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $14.21M+28.9% | $11.02M-2.2% | $11.27M+82.7% | $6.17M-80.7% | $31.92M-15.4% | ||
| $200M-23.1% | $260M-13.3% | $300M-13.3% | $346M+4.8% | $330M+10.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bio-Techne's total assets?
- Bio-Techne (TECH) holds $2.6B in total assets, down 3.5% year over year.
- How much debt does Bio-Techne have?
- Bio-Techne carries $290.3M in total debt against $2.1B of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Bio-Techne have?
- Bio-Techne holds $209.8M in cash and equivalents.
- Can Bio-Techne cover its short-term obligations?
- Its current ratio is 4.49 — current assets exceed current liabilities.
- Where does Bio-Techne's balance sheet data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
